细胞外核酸在膜化中的新型作用:阿托瓦斯塔丁的潜在标
Lana Osman1, Adrian H Chester, Mohamed Amrani
1Imperial College, Royal Brompton and Harefield National Health Service Trust, Harefield, Middlesex, UK.
Circulation
|July 6, 2006
概括
细胞外ATP促进人体膜细胞中的骨质细胞分化,而腺则具有抑制作用. 这表明了形大动脉膜疾病的新型治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 生物化学 生物化学
- 细胞生物学 细胞生物学
背景情况:
- 动脉疾病涉及炎症和骨质母细胞类细胞.
- 细胞外ATP和腺与骨重塑和炎症有关.
- 大动脉膜疾病中的细胞机制尚不清楚.
研究的目的:
- 研究细胞外ATP和腺在人类膜间歇细胞骨质细胞分化中的作用.
- 探索形大动脉膜疾病的潜在治疗点.
主要方法:
- 主要的人类间细胞 (ICs) 被培养并用骨质基质,ATP,ATP-gamma-S和腺治疗21天.
- 使用光谱测量和免疫细胞化学测量了性酸酶 (ALP) 的活性和表达.
- 评估了阿托瓦斯塔丁治疗对ALP活性和ATP分解的影响.
主要成果:
- 在门IC中,ATP和ATP-gamma-S显著增加了ALP活性和表达.
- 单独的腺素并没有影响ALP活性,但减少了骨质原生介质诱导的ALP.
- 阿托瓦斯塔丁抑制了ATP诱导的ALP活性,并增加了ATP分解为腺的速度.
结论:
- 细胞外核酸在诱导人类膜ICs骨质母细胞分化方面发挥着新的作用.
- 这些发现提供了潜在的治疗策略,以预防形大动脉病的进展.
相关概念视频
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
783
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
783
Feedback Regulation of Calcium Concentration
4.2K
Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
4.2K
Antihypertensive Drugs: Action of Calcium Channel Blockers
2.2K
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
2.2K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.8K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.8K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
2.6K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.6K


